Dabrafenib for Treating Unresectable, Advanced or Metastatic BRAF V600 Mutation-Positive Melanoma: An Evidence Review Group Perspective



Fleeman, Nigel ORCID: 0000-0002-4637-9779, Bagust, Adrian ORCID: 0000-0002-2142-5767, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela, Dickson, Rumona ORCID: 0000-0003-1416-0913, Dwan, Kerry, Richardson, Marty, Dundar, Yenal, Davis, Helen and Banks, Lindsay
(2015) Dabrafenib for Treating Unresectable, Advanced or Metastatic BRAF V600 Mutation-Positive Melanoma: An Evidence Review Group Perspective. PHARMACOECONOMICS, 33 (9). 893 - 904.

[img] Text
Dabrafenib_PharmacoEconomics_re-submission_clean.pdf - Accepted Version

Download (657kB)
Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 28 Apr 2017 11:26
Last Modified: 19 Jan 2022 08:30
DOI: 10.1007/s40273-015-0276-9
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3007165